On the other hand, the percentage of intermediate CD14++CD16+ monocytes was lower in KTRs [4.6 (IQR, 2.8–7.3)%] compared to CKD patients [8.2 (IQR, 5.9–11.3)%, p < 0.001]. Here, CD14 is linked to chronic kidney disease.